1
Enquiry period
with 15.08.2022 14:43
to 25.08.2022 10:00
2
Bidding period
with 25.08.2022 10:00
to 15.09.2022 11:00
3
Auction
will not be used
4
Evaluation

5
Contract

Status Evaluation
Estimated value without VAT 5 064 289,13 MDL
Period of clarifications: 15 Aug 2022, 14:43 - 25 Aug 2022, 10:00
Submission of proposals: 25 Aug 2022, 10:00 - 15 Sep 2022, 11:00

Supplier technical support:

(+373) 79999801


This procedure is carried out without auction. Your offer is final and must contain the entire list of required documents.

“Achiziționarea medicamentelor Trastuzumabum 150 mg și Bevacizumabum 400 mg/16 ml necesare IMSP Institutul Oncologic, pentru anul 2022”

Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Full name
Macari Doina
Contact phone
+37322222490
Purchase data
Date created
15 Aug 2022, 14:23
Date modified
15 Aug 2022, 14:43
Achizitii.md ID
21061614
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Open tender
Award criteria
The lowest price
Funding sources
List of lots
Lot nr. 2 - Trastuzumabum 150 mg
Budget: 3351710.88 MDL
Active
Documents of the procurement procedure
Model contract
Bidding Documents
Model de contract
15.08.22 14:43
Propunerea tehnică
Technical Specifications
Propunerea tehnica
15.08.22 14:43
Scrisoare de garantie bancara_Model
Bidding Documents
Scrisoare de garanție OE
15.08.22 14:43
Declaratie beneficiari efectivi_Model
Bidding Documents
Declarație Oe
15.08.22 14:43
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declarație Oe
15.08.22 14:43
Cerere de participare_Model
Bidding Documents
Cerere de participare
15.08.22 14:43
DUAE Model
Bidding Documents
Duae Model
15.08.22 14:43
Anunt de participare.signed
Bidding Documents
Anunț de partcipare
15.08.22 14:43
Propunerea financiară
Technical Specifications
Propunerea financiară
15.08.22 14:43
Documentatia standard.signed
Bidding Documents
Documentația standard
15.08.22 14:43
Only authorized platform users may ask questions during the clarification period.